Sign in to follow
Search Results

0 results for 'Eli Lilly'

You can use to get even better search results
Congress on Verge of Giving False Claims Act Suits a Boost, Just When They Don't Need One
Publication Date: 2009-05-01
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

When the Supreme Court restricted FCA cases against subcontractors in its Allison Engine ruling, whistle-blower lawyers said the court misunderstood congressional intent. The Senate last week passed fast-track legislation to reverse the effects of the high court's ruling--but in the meantime, the Justice Department is settling FCA suits like nobody's business.

Facing Customer Indemnification Demands, Microsoft Calls Another Infringement Filer's Patents Invalid
Publication Date: 2011-04-12
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Microsoft is apparently fed up with patent holding companies allegedly shaking down its customers in East Texas patent suits. The target this time: DataTern, which has sued at least 122 companies since 2008 for allegedly infringing its database software patents.

December 08, 2004 |

Merck Looks to Big-Time Firms for Vioxx Cases

With the initial glare of public scrutiny and market recoil over Vioxx behind it, Merck & Co. now is arming for another battle that will be key in determining the company's survival.
9 minute read
California Supreme Court Eliminates Key Antitrust Defense; Pharma Companies to Face Price-Fixing Suit by Pharmacies
Publication Date: 2010-07-13
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

For more than 40 years, California was out of synch with the U.S. Supreme Court, permitting defendants in state antitrust actions to argue that direct purchasers suffered no harm because they passed price increases on to consumers. With a ruling Monday that eliminates the pass-through defense, California's now in step with the federal courts.

May 01, 2013 |

Stepping Up to the Plate

The general counsel of the baseball players union always goes to bat for his men; and other Moves.
11 minute read
September 12, 2003 |

Federal Circuit Strengthens Patent Protection for Research Tools

In Integra Lifesciences I, Ltd. v. Merck KgaA, the U.S. Court of Appeals for the Federal Circuit dramatically narrowed the safe harbor from patent infringement afforded to drug developers under 35 U.S.C. � 271(e)(1) -- the "safe harbor" provision of the Hatch-Waxman Act -- and restored the vitality of patent rights with respect to research tools.
10 minute read
August 24, 2010 |

Daily Decision Service Alert: Vol. 19, No. 162 - August 24 2010

Daily decision alert.
12 minute read
October 15, 2003 |

Law Firms Become Defendants in Patent Fight

2 minute read
December 07, 2004 |

Awash in Vioxx Suits, Merck Is Recruiting Big-Time Help

Arming for a looming courtroom battle over its Vioxx arthritis drug, Merck & Co. has hired a handful of firms for its defense. The lead firm could receive as much as $50 million for its work on Vioxx litigation, according to observers. In addition to the financial considerations, the task of compiling an outside legal team may present special challenges for a company that highly values privacy and prefers to turn to its in-house lawyers.
9 minute read
May 01, 2001 |

How Cooper Carvin Came Apart

Washington, D.C.-based Cooper, Carvin & Rosenthal was founded only five years ago by two former DOJ officials in the Reagan administration. The firm enjoyed a lucrative and politically charged practice -- until recently. Three top associates were hired away by President George W. Bush and a handful of partners jumped ship. But Charles Cooper, the de facto managing partner of the firm, still says, "I love my practice."
7 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources